Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/archneurpsyc.1959.02340150017002 | DOI Listing |
Oncotarget
January 2025
Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
J Clin Nurs
January 2025
School of Nursing and Midwifery College of Health, Medicine, and Wellbeing Hunter and Medical Research Institute Healthcare Transformation Research Program, The Centre for Transformative Nursing, Midwifery, and Health Research, Hunter New England Local Health District, University of Newcastle, Newcastle, New South Wales, Australia.
Aims: To determine the effectiveness of nurse-led/involved home-based interventions for older people with COPD and to explore the experiences of older people and nurses with the interventions.
Design: A mixed-methods systematic review following the JBI methodology for mixed-methods systematic reviews.
Data Sources: The search included relevant and peer-reviewed studies published from January 2010 to December 2023 in CINAHL, MEDLINE, Cochrane Central Register of Controlled Trials, PsycINFO, EMBASE, JBI, EMCARE and ProQuest.
J Thorac Dis
December 2024
Department of Respiratory Medicine, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China.
Background: Idiopathic pulmonary fibrosis (IPF) has high mortality and poor prognosis, which brings enormous burdens to families and society. We conducted this meta-analysis to analyze and summarize the risk factors associated with mortality in IPF, hoping to provide reference for clinical prevention and treatment of IPF.
Methods: We conducted a comprehensive search of PubMed, Cochrane Library, Embase, and Web of Science from inception to August 10, 2023, to include cohort studies on mortality in patients with IPF.
Cureus
December 2024
Research, Oncology Consultants PA, Houston, USA.
Alzheimer's disease (AD) is the leading cause of dementia, characterized by progressive cognitive decline. Cholinesterase inhibitors are commonly used to manage symptoms but have limited efficacy as the disease progresses. Aducanumab, a monoclonal antibody targeting amyloid-β (Aβ) plaques, has emerged as a novel therapeutic approach.
View Article and Find Full Text PDFVet World
November 2024
Department of Experimental Therapy, Iraqi Center for Cancer and Medical Genetics Research, Mustansiriyah University, Al-Qadisiyah, Baghdad 1001, Iraq.
Background And Aim: Malignant diseases are among the most common and deadly illnesses that are often spread due to lifestyle choices. These diseases are caused by unchecked cell growth, which can be curable if detected early. Cancer treatment is dependent on various internal and external factors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!